Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial.

[1]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[2]  M. Cowley,et al.  Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. , 1987, Journal of the American College of Cardiology.

[3]  R. Roberts.  Reperfusion and the plasma isoforms of creatine kinase isoenzymes: a clinical perspective. , 1987, Journal of the American College of Cardiology.

[4]  E. Topol,et al.  A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. , 1987, Circulation.

[5]  F. Werf,et al.  Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents. , 1986, American heart journal.

[6]  V. Gurewich,et al.  A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity. , 1986, Thrombosis research.

[7]  M. Verstraete,et al.  Synergism of thrombolytic agents in vivo. , 1986, Circulation.

[8]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[9]  W. Nayler,et al.  Reperfusion injury: laboratory artifact or clinical dilemma? , 1986, Circulation.

[10]  H. White,et al.  Improved left ventricular function and early survival with intravenous streptokinase a double blind trial , 1986 .

[11]  E. B. Carlson,et al.  Transluminal catheter reperfusion: a new technique to reestablish blood flow after coronary occlusion during percutaneous transluminal coronary angioplasty. , 1986, The American journal of cardiology.

[12]  B. Pitt,et al.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.

[13]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[14]  E. Braunwald,et al.  Myocardial reperfusion: a double-edged sword? , 1985, The Journal of clinical investigation.

[15]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[16]  Gary Halvorson,et al.  Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985 , 1985 .

[17]  M. Simoons,et al.  IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands , 1985, The Lancet.

[18]  E. Topol,et al.  Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplasty. , 1985, Journal of the American College of Cardiology.

[19]  R. Collins,et al.  Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. , 1985, European heart journal.

[20]  J L Ritchie,et al.  The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.

[21]  R. W. Brower,et al.  RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator , 1985, The Lancet.

[22]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[23]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[24]  J L Ritchie,et al.  Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. , 1983, The New England journal of medicine.

[25]  F. Sheehan,et al.  Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. , 1983, The American journal of cardiology.

[26]  H. Swan.  Thrombolysis in acute myocardial infarction: treatment of the underlying coronary artery disease. , 1982, Circulation.

[27]  R. Erbel,et al.  Percutaneous Transluminal Coronary Angioplasty Immediately After Intracoronary Streptolysis of Transmural Myocardial Infarction , 1982, Circulation.

[28]  A. DeMaria,et al.  Importance of follow-up medical and surgical approaches to prevent reinfarction, reocclusion, and recurrent angina following intracoronary thrombolysis with streptokinase in acute myocardial infarction. , 1982, American heart journal.

[29]  K. Karsch,et al.  Initial experience with transluminal recanalization of the recently occluded infarct‐related coronary artery in acute myocardial infarction — Comparison with conventionally treated patients , 1979, Clinical cardiology.